Jacobs Levy Equity Management, Inc Dexcom Inc Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q3 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Dexcom Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 12,227 shares of DXCM stock, worth $709,899. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,227
Previous 1,372,967
99.11%
Holding current value
$709,899
Previous $120 Million
99.31%
% of portfolio
0.0%
Previous 0.49%
Shares
25 transactions
Others Institutions Holding DXCM
# of Institutions
1,091Shares Held
445MCall Options Held
6.78MPut Options Held
7.25M-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct69.2MShares$4.01 Billion2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.5MShares$2.87 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$979 Million0.04% of portfolio
-
Baillie Gifford & CO15.9MShares$922 Million0.84% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...